12 Best Diagnostics Stocks to Invest In Right Now

Page 7 of 12

6. Agilent Technologies, Inc. (NYSE:A)

Number of Hedge Fund Holders: 55

Agilent Technologies, Inc. (NYSE:A) provides application-focused solutions, including services, instruments, software, and consumables for the entire laboratory workflow. Its offerings allow customers to quantify, identify, and analyze the biological and physical properties of products and substances.

The company drove top-line year-over-year growth in fiscal Q1 2025, with macro market trends continually improving, such as CapEx spending. It reported revenue of $1.681 billion in fiscal Q1 2025, a 1.4% growth over the same quarter last year. This was attributed to the company capturing an outsized share of the China stimulus awards.

Agilent Technologies, Inc. (NYSE:A) plans to grow core revenue between 5% and 7% annually, expanding its operating margin by 50 to 100 plus basis points per year, and delivering double-digit EPS growth. Impax Global Environmental Markets Fund stated the following regarding Agilent Technologies, Inc. (NYSE:A) in its Q3 2024 investor letter:

“Agilent Technologies, Inc. (NYSE:A) (Environmental Testing & Monitoring, US) rebounded during the quarter driven by an encouraging earnings release, indicating improving end-market conditions. Q3 top- and bottom-line results exceeded expectations, driven by strength in their instruments business. Guidance was modestly raised, and the company’s book-to-bill ratio was greater than 1 for the second consecutive quarter.”

Page 7 of 12